| Active Pharmaceutical Ingredients (APIs) | Manufacturing and supply of generic anti-diabetic APIs and contract toll manufacturing for other pharmaceutical ingredients. | EDQM certification, WHO cGMP compliance, established international client base, and increased production capacity providing competitive edge. | B2B customers including pharma manufacturers across Europe, Middle East, South East Asia, and Africa. | Anti-diabetic APIs with strong demand and certification-backed premium pricing. | 19 | 100 | Revenue from API sales and contract manufacturing agreements with pharmaceutical companies. | Direct sales based on supply contracts; pricing linked to volume and quality certifications. | Rising global diabetes prevalence, expanded production capacity, and regulatory approvals fueling export growth. | Metformin Hydrochloride, Glibenclamide |
